Tanaffos، جلد ۲۳، شماره ۳، صفحات ۲۵۰-۲۵۵

عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله

عنوان انگلیسی Changes in Pharmacological Approach to COVID-19 in a Referral Hospital in Tehran During Two Years
چکیده انگلیسی مقاله Background: The current study attempts to look at the trend of medication prescription among inpatients with COVID-19 by comparing two groups of them who were admitted into our hospital at separate times at around two-year intervals. Materials and Methods: Through a retrospective cross-sectional design, the current study enrolled hospitalized cases from two separate periods including winter 2019 and summer 2021 to compare some characteristics of COVID-19 in addition to sex and age distribution as well as the approach and management and their changes as the time passed. Results: Remdesivir was raised to be the most commonly used medication for COVID-19 after one and a half years when approved by the FDA in this regard. Tocilizumab was prescribed for just less than 6% of earlier pandemics in winter 2019 while used in more than half of hospitalizations in 2021. After two years, corticosteroids are used in 98.6% of the cases at least in our center. Conclusion: Exact medication administration to target COVID-19 and accurate vaccination in addition to “Herd immunity” among the global population seems to be the chief secret of the current success at least for partial control of the disease now.
کلیدواژه‌های انگلیسی مقاله COVID-19,Remdesivir,Tocilizumab,Corticosteroids,Medications

نویسندگان مقاله Mehran Marashian |
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mohsen Sadeghi |
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

Somayeh Lookzadeh |
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

Azadeh Moradkhani |
Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Akram Qanavati |
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

Zeinab Chaghervand |
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

Sanaz Soleimani |
Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

Farnaz Hadipour |
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

Maryam Shahmorad |
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mahboobeh Mohammadi |
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

Shirin Esmaeili |
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

Latifeh Javadi |
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

Hooman Sharifi |
Tobacco Prevention and Control Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Esmaeil Idani |
Department of Internal Medicine, School of Medicine, ShahidBeheshti University of Medical Sciences, Tehran, Iran

Hamidreza Jamaati |
Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

Alireza Eslaminejad |
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran


نشانی اینترنتی https://www.tanaffosjournal.ir/article_726115_73f9290a25a0c5223605bfbd7ad0ae68.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات